CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Restricted cash	$ 84.1	$ 80.8
Advances, net	483.4	577.2
Loans held for sale	1,891.7	1,290.2
Receivables, net	189.8	176.4
Other assets, fair value	28.4	15.7
Other assets	273.9	111.3
Advance match funded liabilities	341.9	417.1
Other liabilities, fair value	$ 10.2	$ 28.0
Series B Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Series B Preferred Stock, liquidation preference	$ 25.00	$ 25.00
Series B Preferred Stock, authorized (in shares)	2,400,000	2,400,000
Series B Preferred Stock, issued (in shares)	2,111,786	2,111,787
Series B Preferred Stock, outstanding (in shares)	2,111,786	2,111,787
Common stock, par value per share	$ 0.01	$ 0.01
Common stock, shares authorized	13,333,333	13,333,333
Common stock, shares, issued	8,521,636	7,873,053
Common stock, shares, outstanding	8,521,636	7,873,053
Variable Interest Entity, Primary Beneficiary
Restricted cash	$ 37.3	$ 29.1
Advances, net	364.5	481.8
Loans held for sale	1,199.8	575.4
Receivables, net	64.2	31.9
Other assets	83.4	42.0
Advance match funded liabilities	$ 341.4	$ 416.5